| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.32T | 1.11T | 977.37B | 861.02B | 851.89B |
| Gross Profit | 252.18B | 224.47B | 203.98B | 184.17B | 176.89B |
| EBITDA | 99.86B | 82.33B | 72.87B | 64.84B | 66.21B |
| Net Income | 64.30B | 53.48B | 47.45B | 40.02B | 39.93B |
Balance Sheet | |||||
| Total Assets | 729.20B | 684.85B | 565.20B | 526.13B | 490.20B |
| Cash, Cash Equivalents and Short-Term Investments | 252.06B | 229.53B | 229.66B | 203.31B | 205.78B |
| Total Debt | 7.18B | 6.86B | 8.19B | 8.44B | 8.85B |
| Total Liabilities | 329.61B | 309.60B | 218.25B | 203.40B | 188.43B |
| Stockholders Equity | 394.32B | 370.80B | 343.11B | 319.39B | 298.74B |
Cash Flow | |||||
| Free Cash Flow | 87.85B | 34.49B | 67.66B | 27.95B | 52.67B |
| Operating Cash Flow | 92.22B | 37.71B | 71.65B | 29.20B | 57.87B |
| Investing Cash Flow | -20.48B | -11.95B | -21.47B | -8.36B | -9.16B |
| Financing Cash Flow | -47.61B | -25.89B | -23.84B | -23.31B | -21.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥185.59B | 4.98 | 17.09% | 2.94% | 9.67% | 45.58% | |
76 Outperform | ¥22.01B | 10.49 | ― | 3.83% | 41.87% | 167.99% | |
74 Outperform | ¥49.00B | 13.51 | ― | 4.12% | -4.88% | -26.05% | |
74 Outperform | ¥1.13T | 19.06 | 17.15% | 3.65% | 21.85% | 24.41% | |
65 Neutral | ¥29.53B | -17.27 | ― | 5.16% | 1.71% | -29.37% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥32.58B | 40.99 | 1.55% | 1.34% | -34.13% | -31.24% |